4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001103780-15-000041
CEO bought 112,000 shares at an average $0.18 ($19,636)
From the SEC's structured data for this filing
Trades in this filing
BUNKA CHRISTOPHER · CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-08-10 | Purchase : show line 1 in the form | +5,000 | $0.18 | $875 | 4,940,930 | D |
| 2015-08-10 | Purchase : show line 2 in the form | +10,000 | $0.18 | $1,750 | 4,950,930 | D |
| 2015-08-10 | Purchase : show line 3 in the form | +1,000 | $0.18 | $175 | 4,951,930 | D |
| 2015-08-10 | Purchase : show line 4 in the form | +5,000 | $0.17 | $863 | 4,956,930 | D |
| 2015-08-10 | Purchase : show line 5 in the form | +25,000 | $0.18 | $4,375 | 4,981,930 | D |
| 2015-08-10 | Purchase : show line 6 in the form | +45,000 | $0.18 | $7,875 | 5,026,930 | D |
| 2015-08-10 | Purchase : show line 7 in the form | +11,000 | $0.17 | $1,924 | 5,037,930 | D |
| 2015-08-11 | Purchase : show line 8 in the form | +10,000 | $0.18 | $1,800 | 5,047,930 | D |
| Open-market purchases · 112,000 sh · avg $0.18 · $19,636 | ||||||
Loading xslF345X03/primary_doc.xml…